Non-neuronal dopamine in the gastrointestinal system

Clinical and Experimental Pharmacology and Physiology

Volumn 26, Issue SUPPL., 1999, Pages

  Mezey, E ^a   Eisenhofer, G ^a   Hansson, S ^b   Harta, G ^a   Hoffman, B J ^b   Gallatz, K ^c   Palkovits, M ^c   Hunyady, B ^b,d  

^a NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE   (United States)

^b NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

^c SEMMELWEIS UNIVERSITY OF MEDICINE   (Hungary)

^d First Department of Medicine   (Hungary)

Author keywords

Chemical sympathectomy; Gastrointestinal system; Mucosal protection; Non neuronal dopamine

Indexed keywords

DOPAMINE; DOPAMINE RECEPTOR; MESSENGER RNA; TYROSINE 3 MONOOXYGENASE; DOPAMINE 1 RECEPTOR; DOPAMINE 5 RECEPTOR; DRD5 PROTEIN, HUMAN; DRD5 PROTEIN, RAT;

ANIMAL TISSUE; CELL FRACTIONATION; CHEMICAL SYMPATHECTOMY; CONFERENCE PAPER; CONTROLLED STUDY; DOPAMINE METABOLISM; GASTROINTESTINAL TRACT; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; IMMUNOCYTOCHEMISTRY; IMMUNOELECTRON MICROSCOPY; IN SITU HYBRIDIZATION; MALE; NONHUMAN; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STOMACH PARIETAL CELL; WESTERN BLOTTING; ANIMAL; ARTICLE; CYTOLOGY; DIGESTIVE SYSTEM; HUMAN; METABOLISM; PATHOLOGY; PERFUSION; SPRAGUE DAWLEY RAT;

ANIMALS; DIGESTIVE SYSTEM; DOPAMINE; HUMANS; MALE; PERFUSION; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, DOPAMINE D1; RECEPTORS, DOPAMINE D5; TYROSINE 3-MONOOXYGENASE;

EID: 0033111944     PISSN: 03051870     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (90)

1. Flemström G, Safsten B. Role of dopamine and other stimuli of mucosal bicarbonate secretion in duodenal protection. Dig. Dis. Sci. 1994; 39: 1839-12.
2. MacNaughton WK, Wallace JL. A role for dopamine as an endogenous protective factor in the rat stomach. Gastroenterology 1989; 96: 972-80.
3. Sikiric P, Rotkvic I, Mise S et al. Dopamine agonists prevent duodenal ulcer relapse. A comparative study with famotidine and cimetidine. Dig. Dis. Sci. 1991; 36: 905-10.
4. Szabó S. Dopamine disorder in duodenal ulceration. Lancet 1979; 2: 880-2.
5. Glavin G, Szabó S. Dopamine in gastrointestinal disease. Dig. Dis. Sci. 1990; 35: 1153-61.
6. Glavin GB, Murison R, Overmier JB et al. The neurobiology of stress ulcers. Brain Res. Rev. 1991; 16: 301-43.
7. Glavin G, Dugani A. Effects of dopamine agonists and antagonists on gastric acid secretion and stress responses in stress. Life Sci. 1987; 41: 1397-408.
8. Glavin GB, Activity of selective dopamine DA1 and DA2 agonists and antagonists on experimental gastric lesions and gastric acid secretion. J. Pharmacol. Exp. Ther. 1989; 251: 726-30.
9. Strang R. The association of gastro-duodenal ulceration and Parkinson's disease. Med. J. Aust. 1965; 1: 842-3.
10. Edwards LL, Quigley EM, Pfeiffer RF. Gastrointestinal dysfunction in Parkinson's disease: Frequency and pathophysiology. Neurology 1992; 42: 726-32.
11. Samet ET, White MS, Vaugh AM. Duodenal ulcer in a patient with schizophrenia. Am. J. Dig. Dis. 1957; 2: 437-41.
12. Pollak OJ, Kreplick F. Peptic ulcers in the insane. Clinical and post-mortem study. J. Nerve Ment. Dis. 1945; 101: 1-8.
13. Häggendal J. The presence of dopamine in human gastric juice. Acta Physiol. Scand. 1967; 71: 127-8.
14. Christensen NJ, Brandsborg O, Dopamine in human gastric juice determined by a sensitive double-isotope-derivative technique. Scand. J. Clin. Lab. Invest. 1974; 34: 315-20.
15. Graffner H, Ekelund M, Hakanson R, Oscarson J, Rosengren E, Sundler F, Effects of upper abdominal sympathectomy on gastric acid, serum gastrin, and catecholamines in the rat gut. Scand. J. Gastroenterol. 1984; 19: 711-16.
16. Kawakita N, Nagahala Y, Saitoh Y, Immunohistochernical study of dopamine in rat gastric mucosa with acute gastric ulcer. J. Gastroenterol, 1994; 29: 695-702.
17. Mosin VI, Agranovich NV, Gudzovskii AG. [Dopamine levels in the gastric and duodenal mucosa, blood and urine in patients with duodenal ulcer]. Ter. Arkh. 1987; 59: 18-22 (in Russian).
18. Nishizaki Y. [The effects of exogenous and endogenous dopamine on the gastric microcirculation and their action sites in rat stomach]. Nippon Shokakibyo Gakkai Zasshi 1993; 90: 1639-51 (in Japanese).
19. Häkanson R, Böttcher G, Ekblad E et al. Histamine in endocrine cells in the stomach. Histochemistry. 1986; 86: 5-17.
20. Larsson LI. Gastrointestinal cells producing endocrine, neurocrine and paracrine messengers. Clin. Gastroenterol. 1980; 9: 485-16.
21. Cannata B, Figueroa E, Agucro E, Peralta H, Suarez JR. [Study of gastric secretion in rats with ligation of the pylorus according to the Shay and Dai methods]. Acta Gastroenterol, Latinoam. 1977; 7: 43-6 (in Portuguese).
22. Chayvialle JA, Lambert R, Ruet D, [Effect of esophageal ligation on gastric secretion in rats with pyloric ligation]. Biol. Gastroenterol. 1972; 5: 127-34 (in French).
23. Mozsik G, Karsai T, Teichmann F, Alterations in stomach wall glycoproteins during gastric ulceration induced by pyloric ligation. Digestion 1972; 5: 253-60.
24. Stockhaus K, Wick H. [Modification of gastric juice secretion by saliva of rats with pyloric ligation (Shay rats)]. Arzneimittelforschung 1970; 20: 858-61 (in German).
25. Steinbusch HW, de Wouterlood FGVJ, Bol JG, Berkenhosch F. Immunohistochemical localization of monoamines and cyclic nucleotides. Their application in quantitative immunofluorescence studies and tracing monoaminergic neuronal connections. Acta Histochem. Suppl. 1988; 35: 86-106.
26. Orloff LA, Orloff MS, Bunnett NW, Walsh JH. Dopamine and norepinephrine in the alimentary tract changes after chemical sympathectomy and surgical vagotomy. Life Sci. 1985; 36: 1625-31.
27. Quansah FA, Klatt C, Feldman JM, Effects of diabetes mellitus and chemical sympathectomy on tissue monoamine oxidase activity and norepinephrine concentration in the golden hamster. Metabolism 1981; 30: 242-7.
28. Eisenhofer G, Goldstein D, Stull R et al. Simultaneous liquid-chromatographic determination of 3,4-dihydroxyphenyl-glycol, catecholamines, and 3,4-dihydroxyphenylalanine in plasma and their responses to inhibition of monoamine oxidase. Clin. Chem. 1986; 32: 2030-3.
29. Naoi M, Takahashi T, Nagatsu T, Simple assay procedure tor tyrosine hydroxylase activity by high-performance liquid chromatography employing coulometric detection with minimal sample preparation. J. Chromatogr. 1988; 427: 229-38.
30. Berghorn KA, Bonnett JH, Hoffman GE. cFos immunoreactivity is enhanced with biotin amplification. J. Histochem. Cytochem. 1994; 42: 1635-42.
31. Hunyady B, Krempels K, Harta G, Mezey E, Immunohistochemical signal amplification by catalyzed reporter deposition and its application in double immunostainings. J. Histochem. Cytochem. 1996; 44: 1353-62.
32. Bradley DJ, Towle HC, Young WS. Spatial and temporal expression of alpha- and beta-thyroid hormone receptor mRNAs, including the beta 2-subtype, in the developing mammalian nervous system. J. Neurosci. 1992; 12: 2288-302.
33. Grima B, Lamouroux A, Blanot F, Biguet NF, Mallet J. Complete coding sequence of rat lyrosine hydroxylase mRNA. Proc. Natl Acad. Sci. USA 1985; 82: 617-21.
34. Monsma FJ, Mahan LC, McVittie LD, Gerfen CR, Sibley DR, Molecular cloning and expression of a D1 receptor linked to adenylyl cyclase activation. Proc. Natl Acad. Sci. USA 1990; 87: 6723-7.
35. Tiberi M, Jarvie KR, Silvia C et al. Cloning, molecular characterization, and chromosomal assignment of a gene encoding a second D-1 dopamine receptor subtype: Differential expression pattern in rat brain compared with the DIA receptor. Proc. Natl Acad. Sci. USA 1991; 88; 7491-5.
36. Sokoloff P, Giros B, Martres M-P, Bouthenet M-L, Schwanz J-C. Molecular cloning and characterization of a novel dopamine receptor (D3) as a target for neuroleptics. Nature 1990; 347: 146-51.
37. Van Tol HHM, Bunzow JR, Guan H-C et al. Cloning of the gene for a human dopamine D4 receptor with high affinity for the antipsychotic clozapine. Nature 1991; 350: 610-14.
38. Kilty JE, Lorang D, Amara SG. Cloning and expression of a cocaine-sensitive rat dopamine transporter. Science 1991; 254: 578-9.
39. Erickson JD, Eiden LE, Hoffman BJ. Expression cloning of a reserpine-sensitive vesicular monoamine transporter. Proc. Natl Acad. Sci. USA 1992; 89: 10 993-7.
40. Young WSI. Simultaneous use of digoxigenin- and radiolabeled oligodeoxyribonucleotide probes for hybridization histochemistry, Neuropeptides 1989; 13: 271-5.
41. Smith P, Krohn R, Hermanson G et al. Measurement of protein using bicinchoninic acid. Anal. Biochem. 1985; 150: 76-85.
42. Glavin G, Central antisecretory and peripheral gastroprotective effects of GBR 12909, a selective dopamine uptake inhibitor. Life Sci. 1994; 55: 451-4.
43. Glavin GB, Hall AM. Brain-gut relationships: gastric mucosal defense is also important. Acta Physiol. Hung. 1992; 80: 107-15.
44. Valenzuela JE. Dopamine as a possible neurotransmitter in gastric relaxation. Gastroenterology 1976; 71: 1019-22.
45. Schuurkes JA, Van Nueten JM. Gastric relaxation induced by periarterial (sympathetic?) electrical stimulation in vitro. Scand. J. Gastroenterol. Suppl. 1984; 89; 49-53.
46. Mersereau WA, Hinchey EJ. Role of gastric mucosal folds in formation of focal ulcers in the rat. Surgery 1982; 91: 150-5.
47. Munch G, Raether A, Schoffel E, Illes P. Postsynaptic dopamine DA1- and DA2-receptors in jejunal arteries of rabbits. J. Cardiovasc. Pharmacol. 1991; 18; 468-71.
48. Kullmann R, Breull WR, Wassermann K, Konopatzki A. Blood flow redistribution by dopamine in the feline gastrointestinal tract. Naunyn Schmiedebergs Arch. Pharmacol. 1983; 323: 145-8.
49. Kullmann R, Breull WK, Reinsberg J, Wassermann K, Konopatzki A. Dopamine produces vasodilation in specific regions and layers of the rabbit gastrointestinal tract. Life Sci. 1983; 32: 2115-22.
50. Kullmann R, Breull WR, Reinsberg J, Wassermann K, Konopatzki A. Dopamine produces vasodilation in specific regions and layers of the rabbit gastrointestinal tract. Life Sci. 1983; 32: 2115-22.
51. Germann R, Hasibeder W, Luz G, Effects of low-dose dopamine on gut ischemia in a porcine model of hemorrhagic shock. J. Appl. Physiol. 1993; 74: 1472-3.
52. Germann R, Haisjackl M, Hasibeder W et al. Dopamine and mucosal oxygenation in the porcine jejunum. J. Appl. Physiol. 1994; 77: 2845-52.
53. Lambalgen VA, Kraats VA, Mulder MF, Bos VD, Teerlink T, Thijs LG. Organ blood flow and distribution of cardiac output in dopexamineor dobutamine-treated endotoxemic rats. J. Crit. Care 1993; 8: 117-27.
54. Schmidt H, Secchi A, Wellmann R, Bach A, Bhrer H, Martin E. Dopexamine maintains intestinal villus blood flow during endotoxemia in rats. Crit. Care Med. 1996; 24: 1233-7.
55. Karzai W, Gunnicker M, Scharbert G, Vorgrimler-Karzai UM, Priebe HJ. Effects of dopamine on oxygen consumption and gastric mucosal blood flow during cardiopulmonary bypass in humans. Br. J. Anaesth. 1996; 77: 603-6.
56. Kaise M, Echizen H, Ishizaki T. Dopaminergic control of gastric mucosal blood flow in humans. A study with endoscopic laser Doppler flowmetry coupled with gastric submucosal drug injection. Dig. Dis. Sci. 1993; 38: 1169-74.
57. 99mTc-4-methylaminophenazone clearance technique. Acta Med. Hung. 1987; 44: 157-80.
58. Flemström G, Safsten B, Jedstedt G. Stimulation of mucosal alkaline secretion in rat duodenum by dopamine and dopaminergic compounds. Gastroenterology 1993; 104: 825-33.
59. Knutson L, Knutson TW, Flemstrom G. Endogenous dopamine and duodenal bicarbonate secretion in humans. Gastroenterology 1993; 104: 1409-13.
60. Andersen PH. The dopamine inhibitor GBR 12909: Selectivity and molecular mechanism of action. Eur. J. Pharmacol. 1989; 166: 493-504.
61. Glavin GB, A dopamine D3 receptor agonist, 7-hydroxy-N,N-din-propyl-2-aminotetralin, reduces gastric acid and pepsin secretion and experimental gastric mucosal injury in rats. Life Sci. 1995; 56: 287-93.
62. Glavin GB. Central antisecretory and peripheral gastroprotective effects of GBR 12909, a selective dopamine uptake inhibitor. Life Sci. 1994; 55: PL451-4.
63. 1 on graft perfusion in small bowel transplantation in pigs. Transplant. Proc. 1996; 28: 2549-50.
64. Szabo S. Experimental basis for a role for sulfhydryls and dopamine in ulcerogcnesis: A primer for cytoprotection-organoprotection. Klin. Wochenschr. 1986; 64 (Suppl. 7): 116-22.
65. Eisenhofer G, Aneman A, Friberg P et al. Substantial production of dopamine in the human gastrointestinal tract. J. Clin. Endocrinol. Metab. 1997; 82: 3864-71.
66. Håkanson R. New aspects of the formation and function of histamine, 5-hydroxytryptamine and dopamine in gastric mucosa. Acta Physiol. Stand. 1970; 340 (Suppl.): 1-134.
67. Borowsky B, Hoffman BJ. Neurotransmitter transporters: Molecular biology, function and regulation. In: Bradley RJ, Harris RA (eds). International Review of Neurobiology. Academic Press, San Diego. 1995; 139-99.
68. Liu Y, Peter D, Roghani A et al. A cDNA that suppresses MPP+ toxicity encodes a vesicular amine transporter. Cell 1992; 70: 539-51.
69. Peter D, Liu Y, Sternini C, de Giorgio R, Brecha N, Edwards RH. Differential expression of two vesicular monoamine transporters. J. Neurosci. 1995; 15: 6179-88.
70. Liu Y, Schweitzer ES, Nirenberg MJ, Pickel VM, Evans CJ, Edwards RH. Preferential localization of a vesicular monoamine transporter to dense core vesicles in PC12 cells. J. Cell Biol. 1994; 127: 1419-33.
71. Glavin GB. Dopamine DA1 receptor activation reduces experimentally-induced gastritis in rats. Gen. Pharmacol. 1993; 24: 1481-2.
72. Glavin GB, Hall AM. Central and peripheral dopamine D1/DA1 receptor modulation of gastric secretion and experimental gastric mucosal injury. Gen. Pharmacol. 1995; 26: 1277-9.
73. Germann R, Hasibeder W, Haisjackl M et al. Dopamine-1-receptor stimulation and mucosal tissue oxygenation in the porcine jejunum. Crit. Care Med. 1995; 23: 1560-6.
74. Furuta Y, Hashimoto K, Washizaki M. beta-Adrenoceptor stimulation of exocrine secretion from the rat pancreas. Br. J. Pharmacol. 1978; 62: 25-9.
75. Hashimoto K, Oguro K, Furuta Y. Species difference in the secretory response to dopamine in the pancreas of dogs, cats, rabbits and rats, Arch. Histol. Jpn. 1977; 40 (Suppl.): 129-32.
76. Iijima F, Iwatsuki K, Chiba S. Effects of dopamine on exocrine secretion and cyclic nucleotide concentration in the dog pancreas. Eur. J. Pharmacol. 1983; 92: 191-7.
77. Hashimoto K, Sato S, Takeuchi O, Effect of dopamine on pancreatic secretion in the dog. Br. J. Pharmacol 1971; 43: 739-46.
78. Takeuchi O, Sato S, Hashimoto K. Role of dopamine in the secretory mechanism of the canine pancreas. Tohoku J. Exp. Med. 1971; 104: 203-4.
79. Takeuchi S, Okamura T, Shonai K, Imamura S. Distribution of cate-cholaminergic receptors in the rat's pancreas islet. Nippon Ika Daigaku Zasshi 1990; 57: 119-26.
80. Valenzuela JE, Defilippi C, Diaz G, Navia E, Merino Y. Effect of dopamine on human gastric and pancreatic secretion. Gastroenterology 1979; 76: 323-6.
81. Ziller C, Mirabel MA, Vandenbunder B, Fauquet M. The tyrosine hydroxylase gene is expressed in endoderm and pancreas of early quail embryos. Anal. Embryol. 1994; 189: 307-15.
82. Arluison M, Dietl M, Thibault J. Ultrastructural morphology of dopaminergic nerve terminals and synapses in the striatum of the rat using tyrosine hydroxylase immunocytochemistry: A topographical study. Brain Res. Bull. 1984; 13: 269-85.
83. Dietl M, Arluison M, Mouchet P, Feuerstein C, Manier M, Thibault J. Immunohistochemical demonstration of catecholaminergic cell bodies in the spinal cord of the rat. Preliminary note. Histochemistry 1985; 82: 385-9.
84. Chiodo LA, Kapatos G. Membrane properties of identified mesencephalic dopamine neurons in primary dissociated cell culture. Synapse 1992; 11: 294-309.
85. Rohver H, Acheson AL, Thibault J, Thoenen H. Developmental potential of quail dorsal root ganglion cells analyzed in vitro and in vivo. J. Neurosci. 1986; 6: 2616-24.
86. Vaughan RA. Photoaffinity-labeled ligand binding domains on dopamine transporters identified by peptide mapping. Mol. Pharmacol. 1995; 47: 956-64.
87. van Caffe ARLF, de Ruijs RMVG, Geffard M. Coexistence of vasopressin, neurophysin and noradrenaline immunoreactivity in mediumsized cells of the locus coeruleus and subcoeruleus in the rat. Brain Res. 1985; 338: 160-4.
88. Smolka A, Swiger KM. Site-directed antibodies as topographical probes of the gastric H,K-ATPase alpha-subunit. Biochim. Biophys. Acta 1992; 1108: 75-85.
89. Schafer MKH, Nahr D, Romeo H, Eiden LE, Weihe E. Pan-neuronal expression of chromogranin A in rat nervous system. Peptides 1994; 15: 263-79.
90. Harris J, Ayyub C, Shaw G. A molecular dissection of the carboxyterminal tails of the major neurofilament subunits NF-M and NF-H. J. Neurosci Res. 1991; 30: 47-62.